pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Hematology · news · pharmadog
← back to Hematology
News · Hematology
637
stories
18d
Electra amasses $350M in biotech’s latest big IPO
biopharma dive
18d
Lisata deal propels Marea’s drug pipeline to Wall Street
biopharma dive
18d
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
fda press
18d
Kennedy moves to revive preventive services panel with new members, after months of vacancies
stat
18d
Roche eyes label expansion for Lunsumio after confirmatory lymphoma trial win
endpoints
18d
Purer fentanyl won’t solve the U.S. overdose death crisis, study says
stat
18d
Novartis drops $125M for Sironax’s tech to cross blood-brain barrier
biospace
18d
Longeveron’s shares crash as stem cell therapy flunks mid-stage cardio trial
biospace
18d
Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
fiercebiotech
18d
North Immunology goes public via reverse merger as eczema drug heads toward clinic
fiercebiotech
19d
Novartis to pay $125M for blood-brain barrier crossing platform
biopharma dive
19d
U.S. reaches highest number of measles deaths in decades
stat
19d
Why a US senator wants a biotech leader in the White House who ‘has the president’s ear’
fiercebiotech
19d
Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
fiercebiotech
20d
5 biotechs braving the commercial waters with product launches
biospace
20d
FDA clears first generic radioligand drug; Sionna turns to layoffs
biopharma dive
20d
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
stat
20d
STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more
stat
20d
Businesses can now apply for NIH funding
stat
20d
GSK strikes deal for Chimagen’s T cell engager for blood cancer
endpoints
20d
Exercise — and echocardiograms — in space protected astronauts’ hearts in study
stat
20d
Lilly pledges up to $237M per program in CNS genetic med collab with Canadian biotech
fiercebiotech
21d
GSK doubles down on Chimagen with $750M multiple myeloma wager
fiercebiotech
21d
Blood centers can help biopharma scale cell and gene therapies
biospace
21d
Esophageal pH Monitoring Capsule Recall: Medtronic and Given Imaging Remove Esophageal pH Monitoring Capsule Delivery Device
fda medwatch
21d
A&P Creations LLC Issues Nationwide Recall of biQ-FEL Due to Undeclared Sildenafil and Tadalafil
fda recalls
21d
A&P Creations LLC Issues Nationwide Recall of X10 Natural Enhancement Supplement Due to Undeclared Sildenafil and Tadalafil
fda recalls
21d
Cellectis quits CAR-T and pivots to ‘in vivo’ gene editing
biopharma dive
21d
Axoltis misses the mark in phase 2 ALS study, but will persevere with the synthetic peptide
fiercebiotech
24d
Disc sets up polycythemia vera challenge but Silence maintains lead
biospace
← prev
page 4 of 22
next →
